Repeated maternal intramuscular or intraamniotic erythromycin incompletely resolves intrauterine Ureaplasma parvum infection in a sheep model of pregnancy

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 2, 2014, Pages 134.e1-134.e9

  Kemp, Matthew W ^a   Miura, Yuichiro ^a   Payne, Matthew S ^a   Watts, Rory ^a   Megharaj, Smruthi ^a   Jobe, Alan H ^a,b   Kallapur, Suhas G ^a,b   Saito, Masatoshi ^a,c   Spiller, O Brad ^d   Keelan, Jeffrey A ^a   Newnham, John P ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

erythromycin; infection; preterm birth; sheep; Ureaplasma parvum

Indexed keywords

ERYTHROMYCIN;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; EWE; FEMALE; FETUS; HISTOPATHOLOGY; NONHUMAN; OVINE MODEL; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; SINGLE DRUG DOSE; UREAPLASMA INFECTION; UREAPLASMA PARVUM INFECTION;

ERYTHROMYCIN; INFECTION; PRETERM BIRTH; SHEEP; UREAPLASMA PARVUM;

AMNION; AMNIOTIC FLUID; ANIMALS; ANTI-BACTERIAL AGENTS; CHORION; DNA, BACTERIAL; DRUG ADMINISTRATION SCHEDULE; ERYTHROMYCIN; FEMALE; INJECTIONS; INJECTIONS, INTRAMUSCULAR; INTERLEUKINS; LIVER; LUNG; MODELS, ANIMAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOM ALLOCATION; RNA, BACTERIAL; SERUM AMYLOID A PROTEIN; SHEEP; SKIN; TUMOR NECROSIS FACTOR-ALPHA; UREAPLASMA; UREAPLASMA INFECTIONS;

EID: 84905092434     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.02.025     Document Type: Article

References (32)

1. H. Blencowe, S. Cousens, and M.Z. Oestergaard et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications Lancet 379 2012 2162 2172
2. J.A. Martin, B.E. Hamilton, P.D. Sutton, S.J. Ventura, F. Menacker, and S. Kirmeyer Births: final data for 2004 Natl Vital Stat Rep 55 2006 1 101
3. American College of Obstetricians and Gynecologists Premature rupture of membranes. ACOG Practice Bulletin no. 80 Obstet Gynecol 109 2007 1007 1019
4. S.L. Kenyon, D.J. Taylor, and W. Tarnow-Mordi Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial Lancet 357 2001 979 988
5. B.M. Mercer, R.L. Goldenberg, and A.F. Das et al. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes Semin Perinatol 27 2003 217 230
6. R.L. Goldenberg, W.W. Andrews, and A.R. Goepfert et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants Am J Obstet Gynecol 198 2008 43.e1 43.e5
7. H.E. Jones, K.A. Harris, and M. Azizia et al. Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor PLoS One 4 2009 e8205
8. J.A. Keelan, I. Nitsos, and M. Saito et al. Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep Am J Obstet Gynecol 204 2011 546.e10 546.e17
9. S.J. Dando, I. Nitsos, J.P. Newnham, A.H. Jobe, T.J.M. Moss, and C.L. Knox Maternal administration of erythromycin fails to eradicate intrauterine Ureaplasma infection in an ovine model Biol Reprod 83 2010 616 622
10. M.L. Beeton, V.J. Chalker, N.C. Maxwell, S. Kotecha, and O.B. Spiller Concurrent titration and determination of antibiotic resistance in Ureaplasma species with identification of novel point mutations in genes associated with resistance Antimicrob Agents Chemother 53 2009 2020 2027
11. C.C. Snyder, K.B. Wolfe, and T. Gisslen et al. Modulation of lipopolysaccharide-induced chorioamnionitis by Ureaplasma parvum in sheep Am J Obstet Gynecol 208 2013 399.e1 399.e8
12. J. Yi, B.H. Yoon, and E.C. Kim Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR Mol Cell Probes 19 2005 255 260
13. S.A. Bustin, V. Benes, and J.A. Garson et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin Chem 55 2009 611 622
14. R.D. Bland, and D.W. Nielson Developmental changes in lung epithelial ion transport and liquid movement Ann Rev Physiol 54 1992 373 394
15. M.J. Sanz, Y.N. Abu Nabah, and M. Cerdá-Nicolás et al. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression Br J Pharmacol 144 2005 190 201
16. M. Kacerovsky, L. Pliskova, and R. Bolehovska et al. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation Am J Obstet Gynecol 206 2012 342.e1 342.e8
17. D.C. Kasper, T.P. Mechtler, and G.H. Reischer et al. The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response Diagn Microbiol Infect Dis 67 2010 117 121
18. H. Lode, K. Borner, P. Koeppe, and T. Schaberg Azithromycin: review of key chemical, pharmacokinetic and microbiological features J Antimicrob Chemother 37 suppl 1996 1 8
19. R. Romero, C. Schaudinn, and J.P. Kusanovic et al. Detection of a microbial biofilm in intraamniotic infection Am J Obstet Gynecol 198 2008 135.e1 135.e5
20. K. Pandelidis, A. McCarthy, K.L. Chesko, and R.M. Viscardi Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates Pediatr Infect Dis J 32 2013 394 398
21. K.G. Koski, and M.A. Fergusson Amniotic fluid composition responds to changes in maternal dietary carbohydrate and is related to metabolic status in term fetal rats J Nutr 122 1992 385 392
22. J.M. Vroom, K.J. De Grauw, and H.C. Gerritsen et al. Depth penetration and detection of pH gradients in biofilms by two- photon excitation microscopy Applied Environ Microbiol 65 1999 3502 3511
23. M.L. Beeton, M.R. Daha, T. El-Shanawany, S.R. Jolles, S. Kotecha, and O. Brad Spiller Serum killing of Ureaplasma parvum shows serovar-determined susceptibility for normal individuals and common variable immuno-deficiency patients Immunobiology 217 2012 187 194
24. E.P. McGreal, K. Hearne, and O.B. Spiller Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth Immunobiology 217 2012 176 186
25. S. Pereyre, M. Métifiot, and C. Cazanave et al. Characterization of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics Int J Antimicrob Agents 29 2007 207 211
26. L. Xiao, D.M. Crabb, and L.B. Duffy et al. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp Int J Antimicrob Agents 37 2011 377 379
27. K.B. Waites, P.J. Sims, and D.T. Crouse et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection Pediatr Infect Dis J 13 1994 287 293
28. S. Kenyon, K. Pike, and D.R. Jones et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial Lancet 372 2008 1319 1327
29. S.L. Kenyon, D.J. Taylor, and W. Tarnow-Mordi Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial Lancet 357 2001 989 994
30. F. Higa, and A. Saito Clinical safety of azithromycin Jpn J Antibiot 53 suppl 2000 125 135
31. P.L. Grigsby, M.J. Novy, and D.W. Sadowsky et al. Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model Am J Obstet Gynecol 207 2012 475.e1 475.e14
32. J.A. Keelan, M.W. Kemp, and M.S. Payne et al. Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intraamniotic antimicrobial protection in a pregnant sheep model Antimicrob Agents Chemother 58 2014 447 454